All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying “destabilizing ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Fiona Havers, who oversaw CDC respiratory virus data, told colleagues she no longer had confidence the data would be used ...

A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...

A Seattle infectious disease doctor, whose work was pivotal early in the COVID pandemic, shares more on her experience with ...

GSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...

Secretary of Health and Human Services Robert F. Kennedy Jr.’s decision to fire the Centers for Disease Control and ...

The Affordable Care Act requires all insurance companies to cover, for free, all vaccines the panel recommends. Those ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

Kennedy's decision to "retire" the previous panel was widely decried by doctors' groups and public health organizations.

For this reason, the CDC recommends adults 50 or older schedule the following vaccines, which many people can get for free.

Public health and infectious disease experts said they were surprised and confused about the move, and questioned why the HHS did not offer any reasoning for its decision.